In addition, GBM-associated MDSCs could promote the regulatory function of B cells through delivering membrane-bound PD-L1, endowing Bregs with the potential to inhibit CD8+ T cell activation and acquisition of the effector function 52. This evidence concerns the gene CD8A and glioblastoma.